Platelet Aggregation Inhibitors
"Platelet Aggregation Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
| Descriptor ID |
D010975
|
| MeSH Number(s) |
D27.505.954.502.780
|
| Concept/Terms |
Platelet Aggregation Inhibitors- Platelet Aggregation Inhibitors
- Aggregation Inhibitors, Platelet
- Inhibitors, Platelet Aggregation
- Blood Platelet Antiaggregants
- Antiaggregants, Blood Platelet
- Platelet Antiaggregants
- Antiaggregants, Platelet
- Blood Platelet Aggregation Inhibitors
Antiplatelet Agents- Antiplatelet Agents
- Agents, Antiplatelet
- Antiplatelet Drugs
- Drugs, Antiplatelet
Platelet Antagonists- Platelet Antagonists
- Antagonists, Platelet
- Blood Platelet Antagonists
- Antagonists, Blood Platelet
|
Below are MeSH descriptors whose meaning is more general than "Platelet Aggregation Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Platelet Aggregation Inhibitors".
This graph shows the total number of publications written about "Platelet Aggregation Inhibitors" by people in this website by year, and whether "Platelet Aggregation Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 5 | 2 | 7 |
| 1992 | 2 | 1 | 3 |
| 1993 | 3 | 0 | 3 |
| 1994 | 3 | 0 | 3 |
| 1995 | 1 | 1 | 2 |
| 1996 | 3 | 1 | 4 |
| 1997 | 1 | 0 | 1 |
| 1998 | 2 | 2 | 4 |
| 1999 | 1 | 6 | 7 |
| 2000 | 6 | 2 | 8 |
| 2001 | 9 | 3 | 12 |
| 2002 | 15 | 6 | 21 |
| 2003 | 13 | 3 | 16 |
| 2004 | 21 | 8 | 29 |
| 2005 | 15 | 6 | 21 |
| 2006 | 12 | 5 | 17 |
| 2007 | 6 | 4 | 10 |
| 2008 | 17 | 5 | 22 |
| 2009 | 14 | 8 | 22 |
| 2010 | 8 | 5 | 13 |
| 2011 | 5 | 6 | 11 |
| 2012 | 3 | 6 | 9 |
| 2013 | 8 | 6 | 14 |
| 2014 | 11 | 3 | 14 |
| 2015 | 5 | 2 | 7 |
| 2016 | 9 | 7 | 16 |
| 2017 | 11 | 10 | 21 |
| 2018 | 12 | 5 | 17 |
| 2019 | 12 | 6 | 18 |
| 2020 | 4 | 2 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Platelet Aggregation Inhibitors" by people in Profiles.
-
Ball STE, Taylor R, McCollum CN. Resistance to Antiplatelet Therapy Is Associated With Symptoms of Cerebral Ischemia in Carotid Artery Disease. Vasc Endovascular Surg. 2020 Nov; 54(8):712-717.
-
Kumar A, Huded CP, Zhou L, Krittanawong C, Young LD, Krishnaswamy A, Menon V, Lincoff AM, Ellis SG, Reed GW, Kapadia SR, Khot UN. Implementation of a Comprehensive ST-Elevation Myocardial Infarction Protocol Improves Mortality Among Patients With ST-Elevation Myocardial Infarction and Cardiogenic Shock. Am J Cardiol. 2020 11 01; 134:1-7.
-
Scheitz JF, Pare G, Pearce LA, Mundl H, Peacock WF, Czlonkowska A, Sharma M, Nolte CH, Shoamanesh A, Berkowitz SD, Krahn T, Endres M. High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source. Stroke. 2020 08; 51(8):2386-2394.
-
Costello B, Krajcer Z. Assessing atherothrombotic burden with optical coherence tomography analysis may facilitate post-PCI prognostication and antiplatelet therapy. Catheter Cardiovasc Interv. 2020 07; 96(1):98-99.
-
Sulaica EM, Asias-Dinh BD, Wanat MA, Birtcher KK. Is There Still a Role for Aspirin in Primary Prevention in Women in 2020? Curr Atheroscler Rep. 2020 06 18; 22(8):34.
-
Mohanty A, Srivatsan A, Kan P. Commentary: Antiplatelet Therapy in Flow Diversion. Neurosurgery. 2020 02 01; 86(2):E229-E230.
-
Gitin A, Pfeffer MA, DeMets DL, Hennekens CH. Aspirin in Primary Prevention: Needs Individual Clinical Judgments. Am J Med. 2020 07; 133(7):774-776.
-
Solo K, Lavi S, Kabali C, Levine GN, Kulik A, John-Baptiste AA, Fremes SE, Martin J, Eikelboom JW, Ruel M, Huitema AA, Choudhury T, Bhatt DL, Tzemos N, Mamas MA, Bagur R. Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis. BMJ. 2019 Oct 10; 367:l5476.
-
Khalid U, Bandeali S, Jones PG, Virani SS, Hira R, Hamzeh I, Chan PS, Kleiman NS, Lakkis N, Alam M. Prescription Patterns of Clopidogrel, Prasugrel, and Ticagrelor After Percutaneous Coronary Intervention With Stent Implantation (from the NCDR PINNACLE Registry). Am J Cardiol. 2019 12 15; 124(12):1807-1812.
-
Murthy SB, Biffi A, Falcone GJ, Sansing LH, Torres Lopez V, Navi BB, Roh DJ, Mandava P, Hanley DF, Ziai WC, Kamel H, Rosand J, Sheth KN. Antiplatelet Therapy After Spontaneous Intracerebral Hemorrhage and Functional Outcomes. Stroke. 2019 11; 50(11):3057-3063.